Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and -resistant enterococci

Infection and Immunity

Volumn 68, Issue 8, 2000, Pages 4631-4636

  Huebner, Johannes ^a   Quaas, Alexander ^a   Krueger, Wolfgang A ^a,c   Goldmann, Donald A ^b   Pier, Gerald B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; POLYSACCHARIDE; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFICACY; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; HOSPITAL INFECTION; IMMUNIZATION; IMMUNOCOMPETENCE; IMMUNOTHERAPY; INOCULATION; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROPHYLAXIS; RABBIT;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL CAPSULES; ENTEROCOCCUS FAECALIS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; KIDNEY; LIVER; MICE; OPSONIN PROTEINS; SPLEEN; TEICHOIC ACIDS; VACCINATION; VANCOMYCIN RESISTANCE;

EID: 0033914435     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.8.4631-4636.2000     Document Type: Article

References (40)

1. Arduino, R. C., K. Jacques-Palaz, B. E. Murray, and R. M. Rakita. 1994. Resistance of Enterococcus faecium to neutrophil-mediated phagocytosis. Infect. Immun. 62:5587-5594.
2. Arduino, R. C., B. E. Murray, and R. M. Rakita. 1994. Roles of antibodies and complement in phagocytic killing of enterococci. Infect. Immun. 62:987-993.
3. Bleiweis, A., and R. Krause. 1965. The cell walls of group D streptococci. I. The immunochemistry of the type 1 carbohydrate. J. Exp. Med. 122:237-249.
4. Bleiweis, A. S., F. E. Young, and R. M. Krause. 1967. Cell walls of group D streptococci. II. Chemical studies on the type 1 antigen purified from the autolytic digest of cell walls. J. Bacteriol. 94:1381-1387.
5. Casadevall, A., and M. D. Scharff. 1994. Serum therapy revisited: animal models of infection and development of passive antibody therapy. Antimicrob. Agents Chemother. 38:1695-1702.
6. Chow, J. W., L. A. Thal, M. B. Perri, J. A. Vazquez, S. M. Donabedian, D. B. Clewell, and M. J. Zervos. 1993. Plasmid-associated hemolysin and aggregation substance production contribute to virulence in experimental enterococcal endocarditis. Antimicrob. Agents Chemother. 37:2474-2477.
7. Cohen, M. L. 1992. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science 257:1050-1055.
8. Edmond, M. B., S. E. Wallace, D. K. McClish, M. A. Pfaller, R. N. Jones, and R P. Wenzel. 1999. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin. Infect. Dis. 29:239-244.
9. Elliott, S. 1960. Type and group polysaccharides of group D streptococci. J. Exp. Med. 11:621-630.
10. Gaglani, M. J., C. J. Baker, and M. S. Edwards. 1997. Contribution of antibody to neutrophil-mediated killing of Enterococcus faecalis. J. Clin. Immunol. 17:478-484.
11. Harvey, B. S., C. J. Baker, and M. S. Edwards. 1992. Contributions of complement and immunoglobulin to neutrophil-mediated killing of enterococci. Infect. Immun. 60:3635-3640.
12. Hols, P., S. de Halleux, and J. Delcour. 1992. A strategy to construct vector-free amylolytic strains through nondisruptive homologous recombination: application to Enterococcus faecalis. Gene 118:31-38.
13. Huebner, J., Y. Wang, W. A. Krueger, L. C. Madoff, G. Martirosian, S. Boisot, D. A. Goldmann, D. L. Kasper, A. O. Tzianabos, and G. B. Pier. 1999. Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium. Infect. Immun. 67:1213-1219.
14. Ike, Y., H. Hashimoto, and D. B. Clewell. 1987. High incidence of hemolysin production by Enterococcus (Streptococcus) faecalis strains associated with human parenteral infections. J. Clin. Microbiol. 25:1524-1528.
15. Jett, B. D., and M. S. Gilmore. 1990. The growth-inhibitory effect of the Enterococcus faecalis bacteriocin encoded by pAD1 extends to the oral streptococci. J. Dent. Res. 69:1640-1645.
16. Jett, B. D., M. M. Huycke, and M. S. Gilmore. 1994. Virulence of enterococci. Clin. Microbiol. Rev. 7:462-478.
17. Jett, B. D., H. G. Jensen, R. E. Nordquist, and M. S. Gilmore. 1992. Contribution of the pAD1-encoded cytolysin to the severity of experimental Enterococcus faecalis endophthalmitis. Infect. Immun. 60:2445-2452.
18. Kreft, B., R. Marre, D. Schramm, and R. Wirth. 1992. Aggregation substance of Enterococcus faecalis mediates adhesion to cultured renal tubular cells. Infect. Immun. 60:25-30.
19. Lounatmaa, K., and J. H. Meurman. 1980. Electron microscopic visualization of extracellular polysaccharides on the cell wall of some streptococci. J. Dent. Res. 59:729-735.
20. Maekawa, S., M. Yoshioka, and Y. Kumamoto. 1992. Proposal of a new scheme for the serological typing of Enterococcus faecalis strains. Microbiol. Immunol. 36:671-681.
21. Matthews, K. R., and S. P. Oliver. 1993. Encapsulation of streptococci isolated from bovine milk. Zentbl. Veterinarmed. B 40:597-602.
22. Murray, B. F., K. V. Singh, R. P. Ross, J. D. Heath, G. M. Dunny, and G. M. Weinstock. 1993. Generation of restriction map of Enterococcus faecalis OGl and investigation of growth requirements and regions encoding biosynthetic function. J. Bacteriol. 175:5216-5223.
23. National Nosocomial Infections Surveillance. 1998. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from October 1986-April 1998, issued June 1998. Am. J. Infect. Control 26:522-533.
24. Ostrowsky, B. E., L. Venkataraman, E. M. D'Agata, H. S. Gold, P. C. DeGirolami, and M. H. Samore. 1999. Vancomycin-resistant enterococci in intensive care units: high frequency of stool carriage during a non-outbreak period. Arch. Intern. Med. 159:1467-1472.
25. Pazur, J. H. 1982. β-D-Glucose 1-phosphate: a structural unit and an immunological determinant of a glycan from streptococcal cell walls. J. Biol. Chem. 257:589-591.
26. Pazur, J. H., J. S. Anderson, and W. W. Karakawa. 1971. Glycans from streptococcal cell walls. Imunological and chemical properties of a new diheteroglycan from Streptococcus faecalis. J. Biol. Chem. 246:1793-1798.
27. Pazur, J. H., A. Cepure, J. A. Kane, and C. G. Hellerquist. 1973. Glycans from streptococcal cell walls. The molecular structure of an antigenic diheteroglycan of glucose and galactose from Streptococcus faecalis. J. Biol. Chem. 248:279-284.
28. Pier, G. B., G. J. Small, and H. B. Warren. 1990. Protection against mucoid Pseudomonas aeruginosa in rodent models of endobronchial infection. Science 249:537-540.
29. Pier, G. B., D. Desjardins, M. Grout, C. Garner, S. E. Bennett, G. Pekoe, S. A. Fuller, M. O. Thornton, W. S. Harkonen, and H. C. Miller. Human immune response to Pseudomonas aeruginosa mucoid exopolysaccharide (alginate) vaccine. Infect. Immun. 62:3972-3979.
30. Qin, X., K. V. Singh, Y. Xu, G. M. Weinstock, and B. F. Murray. 1998. Effect of disruption of a gene encoding an autolysin of Enterococcus faecalis OG1RF. Antimicrob. Agents Chemother. 42:2883-2888.
31. Richards, M. J., J. R. Edwards, D. H. Culver, and R. P. Gaynes. 1999. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit. Care Med. 27: 887-892.
32. Schlievert, P. M., P. Gahr, A. P. Assimacupoulos, M. M. Dinges, J. A. Stoehr, J. W. Harmala. H. Hirt, and G. M. Dunny. 1998. Aggregation and binding substances enhance pathogenicity in rabbit models of Enterococcus faecalis endocarditis. Infect. Immun. 66:218-223.
33. Sharpe, M., and P. Shattok. 1952. The serological typing of group D streptococci associated with outbreaks of neonatal diarrhoea. J. Gen. Microbiol. 6:150-165.
34. Sharpe, M. 1964. Serological types of Streptococcus faecalis and its varieties and their cell wall type antigen. J. Gen. Microbiol. 36:151-160.
35. Singh, K. V., X. Qin, G. M. Weinstock, and B. F. Murray. 1998. Generation and testing of mutants of Enterococcus faecalis in a mouse peritonitis model. J. Infect. Dis. 178:1416-1420.
36. Spera, R. V., Jr., and B. F. Farber. 1994. Multidrug-resistant Enterococcus faecium. An untreatable nosocomial pathogen. Drugs 48:678-688.
37. Stevens, S. X., H. G. Jensen, B. D. Jett, and M. S. Gilmore. 1992. A hemolysin-encoding plasmid contributes to bacterial virulence in experimental Enterococcus faecalis endophthalmitis. Investig. Ophthalmol. Vis. Sci. 33: 1650-1656.
38. Wang, Y., J. Huebner, A. O. Tzianabos, G. Martirosian, D. L. Kasper, and G. B. Pier. 1999. Structure of an antigenic teichoic acid shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium. Carbohydr. Res. 316:155-160.
39. Xu, Y., L. Jiang, B. E. Murray, and G. M. Weinstock. 1997. Enterococcus faecalis antigens in human infections. Infect. Immun. 65:4207-4215.
40. Xu, Y., B. E. Murray, and G. M. Weinstock. 1998. A cluster of genes involved in polysaccharide biosynthesis from Enterococcus faecalis OG1RF. Infect. Immun. 66:4313-4323.